GlassScriptPhysician profile
Nathan A Miller
NPI 1073672473
$16,119.11
in general payments reported to CMS, 2019-2025
50 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 77% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $5,016 · 2020: $1,659 · 2021: $3,291 · 2022: $1,424 · 2023: $1,372 · 2024: $1,551 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,729.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,842.58 | 2019-2025 | Eterna, Proclaim, Prodigy |
| Medtronic, INC. | $2,842.65 | 2019-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $2,789.40 | 2019-2020 | |
| Boston Scientific Corporation | $1,780.66 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Infinion 16 |
| Painteq LLC | $265.90 | 2021-2024 | Painteq |
| Flowonix Medical Incorporated | $243.98 | 2019 | |
| Tersera Therapeutics LLC | $237.33 | 2019-2025 | Prialt |
| Saluda Medical Americas, INC. | $217.28 | 2019-2025 | Evoke |
| Grt US Holding, INC. | $204.64 | 2021 | |
| Depuy Synthes Sales INC. | $185.36 | 2019-2024 | Orthovisc |
| Mml US, INC. | $163.86 | 2023 | Reactiv8 |
| Nevro Corp. | $158.09 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $156.84 | 2019-2025 | Sprint Pns System |
| Abbvie INC. | $155.54 | 2021-2025 | |
| Ziehm-Orthoscan, INC. | $143.90 | 2019 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $133.60 | 2024-2025 | Qutenza |
| Electronic Waveform Lab, INC. | $127.84 | 2019-2020 | |
| Curonix LLC | $126.23 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $104.45 | 2023-2025 | Nalu Neurostimulation System |
| Biotissue Holdings INC. | $102.34 | 2023 | |
| Biotronik Nro, INC. | $101.31 | 2025 | Prospera |
| Vertos Medical, INC. | $85.24 | 2022-2024 | Mild Device Kit |
| Pfizer INC. | $82.25 | 2019-2024 | |
| Bioventus LLC | $70.59 | 2025 | Durolane |
| Stimwave Technologies Incorporated | $70.03 | 2021-2022 | |
| Si-Bone, INC. | $60.85 | 2024 | |
| Collegium Pharmaceutical, INC. | $57.38 | 2020-2023 | Belbuca |
| Arbor Pharmaceuticals, INC. | $49.00 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $48.02 | 2023-2025 | Zilretta, Iovera, Exparel |
| Azurity Pharmaceuticals, INC. | $47.82 | 2023-2024 | Horizant, Horizant |
| Relievant Medsystems, INC. | $41.64 | 2022 | |
| Hikma Pharmaceuticals USA | $39.05 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.56 | 2022-2025 | Relistor |
| Masimo Corporation | $37.49 | 2021 | |
| Pacira Therapeutics, INC. | $33.62 | 2019-2021 | |
| Ibsa Pharma INC. | $25.33 | 2025 | Flector, Tirosint, Licart |
| Teva Pharmaceuticals USA, INC. | $24.03 | 2021 | |
| Neuronetics, INC. | $23.96 | 2023 | Neurostar Tms Therapy System |
| Indivior INC. | $22.63 | 2021 | |
| Daiichi Sankyo INC. | $20.45 | 2019 | |
| Ethicon US, LLC | $19.89 | 2024 | Harmonic, Echelon Flex |
| Tonix Medicines, INC. | $19.40 | 2025 | Tonmya |
| Vertiflex, INC. | $18.64 | 2019 | |
| Amgen INC. | $18.35 | 2023 | Prolia, Evenity |
| Stratus Medical, LLC | $16.84 | 2023 | Nimbus |
| Stryker Corporation | $14.92 | 2023 | Ivas |
| Virtus Pharmaceuticals LLC | $14.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.52 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.69 | 2019 | |
| Kaleo, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$152.93 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.